Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.690
-0.460 (-8.93%)
Jul 28, 2026, 3:22 PM EDT - Market open
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $172.17 million as of July 28, 2026. Its market cap has increased by 98.21% in one year.
Market Cap
172.17M
Enterprise Value
545.13M
1-Year Change
98.21%
Ranking
Category
Stock Price
$4.69
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $172.17M, an increase of 271.75%. That is a compound annual growth rate of 19.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 171.07M | -25.18% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 175.19M |
| NervGen Pharma | 173.11M |
| Alpha Cognition | 172.02M |
| LENZ Therapeutics | 171.82M |
| Corbus Pharmaceuticals Holdings | 169.90M |
| Innate Pharma | 169.81M |
| Humacyte | 168.47M |
| Tenaya Therapeutics | 168.17M |